Over the past decade, breakthroughs in genetic science and technological advancements have revolutionized our ability to understand diseases, make diagnoses, and deliver effective treatments. Non-invasive prenatal testing (NIPT) has emerged as a transformative tool in prenatal care, offering a highly accurate screening method for fetal aneuploidy.

The NIPT test, validated by extensive research on nearly 147,000 pregnancies and with over 10 million tests conducted worldwide as of 31 December 2021, stands as a reliable choice for prenatal screening.

This NIPT screens for common trisomies present at birth, including trisomy 21 (Down Syndrome), trisomy 18 (Edwards Syndrome), and trisomy 13 (Patau Syndrome). Additionally, our NIPT offers options for detecting sex chromosomal aneuploidies, chromosomal deletions/duplications, and determining fetal gender. We ensure access to the highest standards of prenatal testing to support expectant parents with accurate and comprehensive insights.

1. Physician Orders test

2. Blood sample collected

3. Sample shipped to laboratory

4. Results sent to Physician